Sodium Bicarbonate → N-[3-(1H-indol-2-yl)-1H-indazol-5-yl]benzenesulfonamide

HRID 25437

반응식

HRID 25437 반응식
C(OC([N:8]1[C:16]2[C:11](=[CH:12][CH:13]=[CH:14][CH:15]=2)[CH:10]=[C:9]1B(O)O)=O)(C)(C)C.C(=O)([O-])O.[Na+].I[C:26]1[C:34]2[C:29](=[CH:30][CH:31]=[C:32]([N:35]([S:43]([C:46]3[CH:51]=[CH:50][CH:49]=[CH:48][CH:47]=3)(=[O:45])=[O:44])C(OC(C)(C)C)=O)[CH:33]=2)[N:28](C(OC(C)(C)C)=O)[N:27]=1>CN(C)C=O>[NH:8]1[C:16]2[C:11](=[CH:12][CH:13]=[CH:14][CH:15]=2)[CH:10]=[C:9]1[C:26]1[C:34]2[C:29](=[CH:30][CH:31]=[C:32]([NH:35][S:43]([C:46]3[CH:51]=[CH:50][CH:49]=[CH:48][CH:47]=3)(=[O:44])=[O:45])[CH:33]=2)[NH:28][N:27]=1

참가 물질

5

반응 조건

온도
122 °C

실험 절차

N-[3-(1H-Indol-2-yl)-1H-indazol-5-yl]benzenesulfonamide can be obtained in the following way: 158.1 mg of N-tert-butoxycarbonylindole-2-boronic acid and 360 μl of a saturated sodium hydrogencarbonate solution and then 48.2 mg of tetrakis(triphenyl-phosphine)palladium[0] are added to a solution of 101.9 mg of tert-butyl 3-iodo-5-(N-tert-butoxycarbonylbenzenesulfonylamino)indazole-1-carboxylate in 4.5 ml of dimethylformamide. The suspension is heated in the region of 122° C. for 16 hours. After cooling to a temperature in the region of 20° C., the catalyst is filtered through a bed of Celite® 535, and the filtrate is concentrated to dryness under reduced pressure. The reaction crude is purified by preparative HPLS chromatography coupled to a mass detector (LC/MS, conditions A). The fractions containing the expected product are pooled and concentrated. 43.8 mg of N-[3-(1H-indol-2-yl)-1H-indazol-5-yl]benzenesulfonamide are obtained in the form of the trifluoroacetate salt (LC/MS analysis: Tr=3.49 minutes; [M+H]+=389.13).

후처리

  1. temperatureAfter cooling to a temperature in the region of 20° C.
  2. filtrationthe catalyst is filtered through a bed of Celite® 535
  3. concentrationthe filtrate is concentrated to dryness under reduced pressure
  4. customThe reaction crude
  5. customis purified by preparative HPLS chromatography
  6. additionThe fractions containing the expected product
  7. concentrationconcentrated

출처 및 근거

ORD 기록
ord-f6f7ddfec69b42338710682d21381dc1
출처 데이터셋
uspto-grants-2005_02
특허 번호
US06858638B2

연결된 노트

불러오는 중…